Medical Science Liaison, Europe Central Region

About BridgeBio Pharma, Inc.  BridgeBio is a biopharmaceutical company dedicated to discovering, developing, and delivering transformative medicines for patients living with genetic diseases and genetically defined cancers. Since our founding in 2015, we have built a diverse portfolio of more than 20 drug development programs, ranging from early discovery to late-stage clinical trials, across multiple therapeutic areas including precision oncology, cardiology, endocrinology, neurology, and renal disease.

We have already achieved regulatory approval for three therapies and continue to advance promising science from academia into meaningful treatments for patients worldwide.  Who We Are  BridgeBio is a global biotechnology company with our Global Headquarters located in San Francisco, USA, and our International HQ located in Zug, Switzerland.

Since establishing our European presence in 2021, we’ve been building empowered, high-performing teams across countries — with experienced colleagues who move quickly, take ownership, and are fueling the company’s international growth.  At BridgeBio, you’ll find an energetic and collaborative culture where pragmatism meets bold decision-making.

We embrace uncertainty with confidence, guided by our commitment to making a meaningful impact for patients. Our people are trusted and empowered, united by urgency, purpose, and the drive to advance science for patients around the world.  To learn more about our story and company culture, visit us at https://bridgebio.com What You'll Do You will report to the Senior Medical Director, Europe Central Region, and work closely with fellow Medical Science Liaisons, local Market Access, and regional and global Medical Affairs teams.

Together, you will execute the Medical Affairs brand plan and strategic initiatives that support BridgeBio’s mission to deliver transformative medicines for patients with genetic diseases and genetically driven cancers.  Your primary purpose will be to build our KOL and HCP base in the pre-launch and launch phase, as BridgeBio engages with most customers in Germany for the first time. You will work on our initiatives during early pre-launch through post-launch, ensure medical and scientific education of HCPs as part of our launch efforts, engage with HCPs to increase diagnosis rates and support market access related work as a key stakeholder.  This role requires effective collaboration with cross-functional colleagues and external stakeholders to ensure high-quality execution and impact.

The ideal candidate combines deep expertise in medical and scientific engagement in the context of introducing a biotech company for the first time to KOLs, medical and scientific engagement and making a remarkable contribution to a disease space in pre-launch and launch phase in a rare disease and orphan condition.

We look for strong communication skills, adaptability, and the ability to thrive in a fast-paced, hands-on environment.  Responsibilities Identify relevant HCPs and map the treatment landscape in scope, including patient journey with diagnosis, treatment, referral and centers of excellence Deliver pre-launch activities to ensure medical readiness, including disease state education, unmet need articulation, initiatives to significantly improve diagnosis rates, and structured scientific exchange planning and KOL engagement Support identification, prioritization, and delivery of high-impact medical research initiatives aligned with business objectives, including BridgeBio-sponsored and investigator-initiated studies, for generation of locally relevant data Co-design and deliver insight-generation and medical education activities, including advisory boards, congress symposia, standalone meetings, hospital-based education, and speaker development programs Leverage AI and digital technologies to enhance medical insights generation, stakeholder engagement, knowledge management, and operational efficiency, ensuring compliant, ethical, and value-driven use of emerging digital solutions Regular review of relevant literature, participation in scientific congresses and conferences, including BridgeBio therapeutic area training sessions to maintain current knowledge and to develop competitive intelligence on other treatments in the therapeutic area Design and deliver internal training materials and sessions for onboarding of new colleagues as well as continuous education, and support review of materials The above job description documents the general nature and level of work but is not intended to be an exhaustive list of activities, duties, and responsibilities required of job incumbents.

Therefore, job incumbents are expected to perform all other duties as assigned or required, as training and experience allow.  Where You'll Work This is a Germany-based, field-facing role with a strong customer engagement component. The position requires travel throughout Germany, as well as periodic travel across Europe for conferences, KOL meetings, and speaker programs.  Local team meetings and designated office location in Germany is Munich.

Who You Are

Master of Science degree required. PhD, PharmD, or MD preferred Minimum 5-7 years of field-based Medical Affairs experience in rare diseases and orphan conditions  Experience in endocrinology and achondroplasia or bone growth disorders with a genetic cause is a plus Excellent interpersonal communication and presentation skills, including the ability to network.

Able to participate in a scientific dialogue with KOLs and researchers Proven ability to create and sustain relationships with key scientific experts, and to handle objections and manage issues presented by HCPs Experience in initiating diagnostics initiative is a plus Self-starter, entrepreneurial, with can-do mindset and ability and willingness to organize, prioritize, and work effectively with minimal supervision in a biotech build-out environment Rewarding Those Who Make the Mission Possible We have high expectations for our team members.

We make sure those working hard for patients are rewarded and cared for in return.   Market leading compensation Hybrid work model - we value your flexibility in how you work, but encourage time in the office to strengthen our culture, collaboration, and sense of community We provide career development through regular feedback, continuous education and professional development programs We celebrate strong performance with financial rewards, peer-to-peer recognition, and growth opportunities

BridgeBio Pharma (NASDAQ: BBIO) is a biopharmaceutical company dedicated to advancing a diverse pipeline of medicines that target genetic diseases. Founded in 2015, BridgeBio is committed to developing innovative therapies that address unmet medical needs in various rare and genetic diseases. With a focus on precision medicine and a patient-centered approach, BridgeBio is at the forefront of revolutionizing treatment options for individuals affected by genetic disorders.